DrugDashboards

Levetiracetam in Sodium Chloride

Levetiracetam · LEVETIRACETAM 10 mg/mL · Injection · Intravenous · Nexus Pharmaceuticals LLC

NDC 14789-0220-10 · 10 BAG in 1 CARTON / 100 mL in 1 BAG · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.0320per billing unit (10 MG)HCPCS J1953 · Jul 1, 2026
  • Part D plans paid (avg)$10.38per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.032
HCPCS J1953 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$553
241 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $52.15 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA213532
TE code
AP
Approval date
Jul 6, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Levetiracetam (Injection)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.LEVETIRACETAM 100 mg/mLJul 15, 2026Sep 3, 2026
Armas Pharmaceuticals Inc.LEVETIRACETAM 100 mg/mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.LEVETIRACETAM 10 mg/mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.LEVETIRACETAM 5 mg/mLJul 15, 2026Sep 2, 2026
B. Braun Medical Inc.LEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLEVETIRACETAM 10 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLEVETIRACETAM 5 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.LEVETIRACETAM 100 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLEVETIRACETAM 10 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLEVETIRACETAM 5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedLEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedLEVETIRACETAM 5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedLEVETIRACETAM 10 mg/mLJul 15, 2026Sep 2, 2026
Hp Halden Pharma ASLEVETIRACETAM 5 mg/mLJul 15, 2026Sep 2, 2026
Hp Halden Pharma ASLEVETIRACETAM 10 mg/mLJul 15, 2026Sep 2, 2026
Hp Halden Pharma ASLEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
Method Pharmaceuticals, LLCLEVETIRACETAM 500 mg/5mLJul 15, 2026Sep 2, 2026
Micro Labs LimitedLEVETIRACETAM 100 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCLEVETIRACETAM 5 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCLEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCLEVETIRACETAM 10 mg/mLJul 15, 2026Sep 2, 2026
Nexus Pharmaceuticals LLCLEVETIRACETAM 10 mg/mLJul 15, 2026Sep 2, 2026
Nexus Pharmaceuticals LLCLEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
Nexus Pharmaceuticals LLCLEVETIRACETAM 5 mg/mLJul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCLEVETIRACETAM 500 mg/5mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCLEVETIRACETAM 15 mg/mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCLEVETIRACETAM 5 mg/mLJul 15, 2026Aug 31, 2026
WG Critical Care, LLCLEVETIRACETAM 10 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Levetiracetam in Sodium Chloride — NDC 14789-0220-10," retrieved September 3, 2026, https://drugdashboards.com/drug/14789022010.

Free to cite with attribution — see how the data is put together.